Heterocyclic GLP-1 agonists
US11926626B2 · kind B2 · utility
1Cited by
0References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 21, 2022 |
| Grant date | Mar 12, 2024 |
| Priority date | — |
| Expiry date | Nov 1, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure relates to GLP-1 agonists of Formula (I), including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.